NLS Collaboration

Nordic Nanovector has entered into a research and development collaboration programme with Paul Scherrer Institute (PSI) in Switzerland. The collaboration aims at developing new antibody radionuclide conjugates (ARCs) optimised for the treatment of single cell leukaemias, such as chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). CLL and AML are serious orphan diseases with […]

Binding Site collaborates with Prof Sigurdur Kristinsson of the University of Iceland in his pivotal MGUS screening study for the forthcoming iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial. The study will examine blood samples from approximately 140,000 adults over age 40 in Iceland for the earliest signs of myeloma. A cancer of the […]

The spin-off company, and Umeå Biotech Incubator project, Lipigon Pharmaceuticals and AstraZeneca have entered a research collaboration to develop a high throughput assay for the identification of molecules against elevated blood lipids. Lipoprotein lipase (LPL) is a promising target for development of new medicines for dyslipidemia and other cardiometabolic risk markers. Recent evidence from genetic- […]

PharmaResearch Products and Lipopeptide have entered a strategic collaboration to co-develop and market two therapeutic peptides that have been developed by Lipopeptide AB through Phase II. The products are aimed for advanced wound care. The two companies will collaborate on the clinical development and marketing of PXL01, a novel therapeutic peptide for prevention of post-surgical […]

Oncurious NV, an oncology company focused on the development of orphan drugs for the treatment of pediatric tumors, has signed a partnership with the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), a collaboration of 25 US academic medical centers, teaching hospitals and other entities, with the purpose of facilitating and conducting collaborative research activities and […]

Finnish BC Platforms will collaborate with Microsoft to use the Microsoft Azure cloud platform and services to provide integrated genomic data management solutions in healthcare. Microsoft Corp. and BC Platforms will build the first proof of concept case with Helsinki University Hospital in 2016. “Microsoft is the first cloud provider recognized by the European Union’s […]